Photo Credit: iStock
Currently, there are 70 vaccines in development globally. 3 of them are in human trials. The furthest-along candidate, an experimental vaccine developed by the Beijing Institute of Biotechnology and the Hong Kong-listed CanSino Biologics, is currently in phase 2 trials.